SCHEMBL7251855

SCHEMBL7251855

O=C1SC(c2cccc(F)c2)N(CCCCl)C1=O

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.42
HTR7 P34969 4/20 0.41
HTT P42858 2/20 0.40
HPGD P15428 2/20 0.40
GFER P55789 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7249663 0.87 ACHE (0.48) ACHEL3MBTL1HTR7HTTHPGD
SCHEMBL7257221 0.86 ACHE (0.49) ACHEHTTHPGDALDH1A1TSHR
SCHEMBL7249964 0.84 CACNA1B (0.45) HTR7HTTKMT2AMEN1ALDH1A1
SCHEMBL7251754 0.81 KMT2A (0.48) HTTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL7255245 0.79 ACHE (0.71) ACHEHTR7GFERALDH1A1
SCHEMBL7249569 0.74 ACHE (0.48) ACHEHTTHPGDALDH1A1TSHR
SCHEMBL7255088 0.68 KMT2A (0.46) HTTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL28484694 0.67 GFER (0.47) ACHEHTR7GFERKMT2AALDH1A1
SCHEMBL7248241 0.67 ACHE (0.41) ACHEGFERKDM4E
SCHEMBL7248243 0.67 ACHE (0.41) ACHEGFERKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US disclosed